These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 20551400)

  • 1. Medication helps make therapy work for teens addicted to prescription opioids.
    Kuehn BM
    JAMA; 2010 Jun; 303(23):2343-5. PubMed ID: 20551400
    [No Abstract]   [Full Text] [Related]  

  • 2. A retrospective study of retention of opioid-dependent adolescents and young adults in an outpatient buprenorphine/naloxone clinic.
    Matson SC; Hobson G; Abdel-Rasoul M; Bonny AE
    J Addict Med; 2014; 8(3):176-82. PubMed ID: 24695018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of adolescent opioid dependence: no quick fix.
    Fiellin DA
    JAMA; 2008 Nov; 300(17):2057-9. PubMed ID: 18984896
    [No Abstract]   [Full Text] [Related]  

  • 4. Prescription drug monitoring programs and buprenorphine maintenance: clinical considerations.
    Hoefer M; Petrakis I
    Am J Addict; 2014; 23(6):616-7. PubMed ID: 25251308
    [No Abstract]   [Full Text] [Related]  

  • 5. In brief: Buprenorphine/naloxone (Zubsolv) for opioid dependence.
    Med Lett Drugs Ther; 2013 Oct; 55(1427):83. PubMed ID: 24129113
    [No Abstract]   [Full Text] [Related]  

  • 6. Tramadol dependence: treatment with buprenorphine/naloxone.
    Ritvo JI; Koonce R; Thurstone CC; Causey HL
    Am J Addict; 2007; 16(1):67-8. PubMed ID: 17364425
    [No Abstract]   [Full Text] [Related]  

  • 7. Time to include buprenorphine-naloxone combination in the WHO Model List of Essential Medicines.
    Balhara YP
    J Opioid Manag; 2013; 9(4):237. PubMed ID: 24380101
    [No Abstract]   [Full Text] [Related]  

  • 8. Office-based practice and opioid-use disorders.
    Clark HW
    N Engl J Med; 2003 Sep; 349(10):928-30. PubMed ID: 12954740
    [No Abstract]   [Full Text] [Related]  

  • 9. 23-year-old woman being treated for opioid dependence, unexpected weight gain.
    Chudgar NP; Greenblatt L
    J Fam Pract; 2014 Jul; 63(7):366-7. PubMed ID: 25198209
    [No Abstract]   [Full Text] [Related]  

  • 10. Loperamide Addiction: Atypical Opioid Use Disorder Treated With Buprenorphine/Naloxone.
    Varghese SP; Kumari P; Wijegunaratne H; Yovankin T; Garlapati V; Koola MM
    Prim Care Companion CNS Disord; 2019 Jul; 21(4):. PubMed ID: 31274259
    [No Abstract]   [Full Text] [Related]  

  • 11. Less pain, more gain: buprenorphine-naloxone and patient retention in treatment.
    Renzelli CM; Capretto NA
    J Addict Dis; 2006; 25(3):97-104. PubMed ID: 16956874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Buprenorphine maintenance: a new treatment for opioid dependence.
    Collins GB; McAllister MS
    Cleve Clin J Med; 2007 Jul; 74(7):514-20. PubMed ID: 17682629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New pharmacological tool approved for opioid addiction.
    Sansovich D
    HIV Clin; 2004; 16(3):9-11. PubMed ID: 15366107
    [No Abstract]   [Full Text] [Related]  

  • 14. Medication-Assisted Treatment of Opioid Use Disorder in Adolescents and Young Adults.
    Cottrill CB; Matson SC
    Adolesc Med State Art Rev; 2014 Aug; 25(2):251-65. PubMed ID: 27132312
    [No Abstract]   [Full Text] [Related]  

  • 15. Opioid Use Disorders.
    Sharma B; Bruner A; Barnett G; Fishman M
    Child Adolesc Psychiatr Clin N Am; 2016 Jul; 25(3):473-87. PubMed ID: 27338968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Food and Drug Administration approval of buprenorphine-naloxone for office treatment of addiction.
    Resnick RB
    Ann Intern Med; 2003 Feb; 138(4):360. PubMed ID: 12585846
    [No Abstract]   [Full Text] [Related]  

  • 17. The Time Is Now: The Role of Pharmacotherapies in Expanding Treatment for Opioid Use Disorder.
    Gordon AJ; Jenkins JA
    Subst Abus; 2015; 36(2):127-8. PubMed ID: 25826044
    [No Abstract]   [Full Text] [Related]  

  • 18. Modeling longitudinal changes in buprenorphine treatment outcome for opioid dependence.
    Saleh MI
    Pharmacopsychiatry; 2014 Nov; 47(7):251-8. PubMed ID: 25321188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment Persistence Among Insured Patients Newly Starting Buprenorphine/Naloxone for Opioid Use Disorder.
    Shcherbakova N; Tereso G; Spain J; Roose RJ
    Ann Pharmacother; 2018 May; 52(5):405-414. PubMed ID: 29302989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating opioid addiction with buprenorphine-naloxone in community-based primary care settings.
    Mintzer IL; Eisenberg M; Terra M; MacVane C; Himmelstein DU; Woolhandler S
    Ann Fam Med; 2007; 5(2):146-50. PubMed ID: 17389539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.